News

The stock's price has risen nearly 50% this year.

Lemonade is facing a brutal sell-off despite posting strong sales growth in Q2.

(Updates with index/price moves and Fed/company/geopolitical news from the first paragraph.) US e

Chip stocks extended a losing streak while traders await Fed Chair Kevin Warsh's rate announcement Wednesday afternoon

As the Federal Reserve gets set to release its monetary policy update at 2 p.m. ET, followed a half hour later by Chairman Kevin Warsh's news conference, Wall Street is the unusual position of not knowing what will happen. Prior to Warsh, Wall Street has typically been near certain about what the Fed would do, reflected by markets pricing in around 90% or higher odds of the expected result. The S&P 500 is sharply lower ahead of the Fed reveal, amid rebounding oil prices and the ongoing sell-off in AI and chip names.

The FTSE 100 was lifted by well-received earnings and gains in BP and Shell as the oil price strengthened.

Those who stay patient and disciplined, while ignoring the noise, will find that the market stacks the odds in their favor.

SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.

SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.

The company's mission to establish humanity on other planets has fired up the investment community.

During an interview with Fox News on Wednesday, Trump warned that the United States will be “hitting Iran hard” following the attack on U.S. bases in Jordan.

U.K. stocks have been out in the cold for much of 2026. Without a buzzy AI stock to its name, the FTSE 100 index lagged global peers. But a rout in chip stocks seems to have heralded a change in fortunes for London's premier index.

GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on Q1 results. Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.

Ares Capital has a 10% yield and a volatile dividend history, with recessions being particularly difficult.

July has been a rough month for some AI stocks.

Score one for the bulls.

Mark Zuckerberg is making the rounds of the business press with a very public campaign to reshape AI regulation, but the real story is what his lobbying reveals about Meta's increasingly desperate position in the AI race.

The latest oil spike was sending the Dow tumbling, but the Federal Reserve’s interest-rate decision and a gauntlet of earnings loom. The Dow Jones Industrial Average fell 700 points, or 1.3%. The S&P 500 was down 0.

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.

Ford announced an operating profit of $2.5 billion from sales of $48.3 billion. Things look OK for the U.S. car business.

Most covered call investors have piled into the same two giant indexes, but a handful of overlooked ETFs are harvesting premiums from corners of the market JEPI and QYLD never touch.

West Texas Intermediate crude jumped nearly 7% after Iran launched missiles at U.S. forces, complicating the Fed's rate calculus

Options imply a 6.6% move after earnings.

Coca-Cola's stock is running hot on the back of a genuinely powerful business, forcing investors to decide if they are looking at a mid-race surge or the finish line.

The healthcare fund just printed a record high, but cashing out of a steady compounder is often the wrong move.

Wall Street faces a twin set of risks on Wednesday, tied to Big Tech earnings and a Federal Reserve interest-rate decision, as stocks undergo a rare change of leadership ahead of the summer market doldrums. “The market’s response to both should provide a clearer indication of whether the current rotation continues or begins to develop into broader weakness,” said Zaheer Anwari, co-founder and CEO of the Luxembourg-based Revacy Fund.

Stock Market Today: The Dow Jones index dropped Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. SK Hynix sold off.

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

Ace River Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Ace River Capital Partners reported a +6.25% return in the first half of 2026, trailing the S&P 500’s +9.55% and Russell 2000’s +22.57% returns. Despite short‑term underperformance, the fund emphasizes long‑term compounding through concentrated […]

Ace River Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Ace River Capital Partners reported a +6.25% return in the first half of 2026, trailing the S&P 500’s +9.55% and Russell 2000’s +22.57% returns. Despite short‑term underperformance, the fund emphasizes long‑term compounding through concentrated […]